Companies · Healthtech

Diameter Health, Inc.

Farmington · Healthtech · refined from filed group “Other Technology

Diligence memoA one-page analyst read on Diameter Health, Inc. — recommendation, valuation, rhythm, risks.
$30.7M
Total raised · real
5
Rounds
1.9×
Latest step-up
Top 15%
Sector rank · raised
Series B
Latest stage · inferred · Fri Sep 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Diameter Health, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.94× the median modeled value of Series B Healthtech companies in 2019–2021 (56 peers) — value vs value, same stage and era.
  • Within the normal band (94% of peer median) for its niche.
Dormant
  • Last raise 5.8 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Diameter Health, Inc. is one of 2138 Healthtech companies tracked from Farmington. By capital raised it ranks in the upper tier (ahead of 86% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
5
Investors (latest)
2020-09-11
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MPre-Seed · 2015-04-30 Raised $227K (real) Modeled valuation $7.8M (est)$227K$7.8MPre-Seed2015Seed · 2016-02-16 Raised $1.8M (real) Modeled valuation $51M (est)$1.8M$51MSeed2016Seed · 2018-05-11 Raised $1.1M (real) Modeled valuation $30M (est)$1.1M$30MSeed2018Series A · 2019-01-29 Raised $9.6M (real) Modeled valuation $217M (est)$9.6M$217MSeries A2019Series B · 2020-09-11 Raised $18M (real) Modeled valuation $419M (est)$18M$419MSeries B2020+$1.8M+$1.1M+$9.6M+$18MCumulative $31M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$227K · 2015
Seed$1.8M · 2016
Seed extension$1.1M · 2018
Series A$9.6M · 2019
Series B$18.0M · 2020

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$418.7M
Base estimate est.
$42.3M
Conservative case
$1.6B
Upside case
$100.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $7.8M · 2015-04-302015Seed · modeled $51.2M · 2016-02-16Seed · modeled $29.8M · 2018-05-11Series A · modeled $216.7M · 2019-01-29Series B · modeled $418.7M · 2020-09-112020
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.38×/yr
Annual markup
1.67×/yr upside case
5.8 yr
Elapsed time used
5.8 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
16 mo
Avg between rounds
$5.7M/yr
Capital velocity
11.2 yr
On record since
2015
First round
5
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 6.9× above median
This company$30.7M
Sector median$4.5M
Latest round — vs other Series B rounds in sector (real $, this stage) 1.0× of median
This company$18.0M
Sector median$18.3M
Modeled value — vs sector median (estimate, all stages) 12× above median
This company$418.7M
Sector median$33.8M

Raised more than 86% of sector peers (real $). Modeled value above 92% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #34 of 56.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0M$1.0BCapital raised (log)Solera Health, Inc. · Series B Raised $79.1M · modeled $935.6M (est)Icebreaker Health, Inc. · Series B Raised $51.5M · modeled $890.1M (est)Buoy Health, Inc. · Series B Raised $66.7M · modeled $837.4M (est)Stroma Medical Corp · Series B Raised $43.0M · modeled $767.6M (est)HealthJoy, Inc. · Series B Raised $45.5M · modeled $743.5M (est)Appriss Health Holdings, Inc. · Series B Raised $38.1M · modeled $718.0M (est)Superconductive Health, Inc. · Series B Raised $61.0M · modeled $717.0M (est)Wheel Health, Inc. · Series B Raised $36.7M · modeled $686.1M (est)Mindoula Health, Inc. · Series B Raised $30.7M · modeled $663.2M (est)Flowonix Medical Inc · Series B Raised $104.6M · modeled $656.8M (est)Sirona Medical, Inc. · Series B Raised $53.0M · modeled $638.3M (est)HealthPlan One Holdings, Inc. · Series B Raised $28.6M · modeled $621.6M (est)Diameter Health, Inc. (this company) Raised $30.7M · modeled $418.7M (est)Diameter Health, Inc.
CompanyStageRaised · realValue · estvs peer med.
Solera Health, Inc.Series B$79.1M$935.6M2.09×
Icebreaker Health, Inc.Series B$51.5M$890.1M1.99×
Buoy Health, Inc.Series B$66.7M$837.4M1.87×
Stroma Medical CorpSeries B$43.0M$767.6M1.72×
HealthJoy, Inc.Series B$45.5M$743.5M1.66×
Appriss Health Holdings, Inc.Series B$38.1M$718.0M1.61×
Superconductive Health, Inc.Series B$61.0M$717.0M1.60×
Wheel Health, Inc.Series B$36.7M$686.1M1.53×
Mindoula Health, Inc.Series B$30.7M$663.2M1.48×
Flowonix Medical IncSeries B$104.6M$656.8M1.47×
Sirona Medical, Inc.Series B$53.0M$638.3M1.43×
HealthPlan One Holdings, Inc.Series B$28.6M$621.6M1.39×
Diameter Health, Inc. this companySeries B$30.7M$418.7M0.94×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$227K2015-04-30$1.3M$7.8M85%
Seed$1.8M2016-02-16$9.2M$51.2M85%
Seed$1.1M2018-05-11$5.4M$29.8M90%
Series A$9.6M2019-01-29$43.6M$216.7M90%
Series B$18.0M2020-09-11$100.0M$418.7M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$227K2015-04-30
    • First recorded raise — entered as Pre-Seed.
    • 9 investors on this round.
  2. Seed$1.8M2016-02-16
    • Raised 10 mo later, in step with the ~14 mo sector norm.
    • Round 8.2× larger than the prior — scaling up.
    • 16 investors on this round.
  3. Seed$1.1M2018-05-11
    • Raised again after 27 mo — slower than the ~14 mo sector norm.
    • Round 1.7× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  4. Series A$9.6M2019-01-29
    • Raised 9 mo later, in step with the ~14 mo sector norm.
    • Round 8.9× larger than the prior — scaling up.
    • 20 investors on this round.
  5. Series B$18.0M2020-09-11
    • Raised 19 mo later, in step with the ~14 mo sector norm.
    • Round 1.9× larger than the prior — scaling up.
    • 5 investors on this round.
Intelligence
2022 ~Q1
Modeled next raise · ~16mo cadence
$33.8M
Modeled next size est.range $21.9M$54.0M
1.9×
Last step-up
$5.7M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Mark Anderson19 other2019-01
Matthew Storeygard5 other2019-01
Word D. Peake4 other2018-05
Word D. Peake III3 other2020-09
Michael Cunningham2 other2020-09
Richard Dumler2 other2016-02
Sarah London2 other2020-09
Eric Rosow1 other2015-04
Matthew D. Storeygard1 other2016-02
Geoff Hogan2019-01
Harvard Pan2019-01
John D'Amore2015-04
Kimberly Howland2019-01
Mark D. Andersen2018-05
Sarah D. London2019-01
Registry & provenance

Diameter Health, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1642752
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Inbox Health Corp.HealthtechSeries B$49.9M$48.6Mnetwork2 shared operators · same sector · same stage
Humata Health, Inc.HealthtechSeries B$25.0M$174.5Mnetwork1 shared operator · same sector · same stage
Greater Good Healthcare Inc.HealthtechSeries B$41.9M$74.6Mnetwork1 shared operator · same sector · same stage
Mindoula Health, Inc.HealthtechSeries B$30.7M$663.2Msame sector · same stage
Sift Medical Data, Inc.HealthtechSeries B$30.7M$143.6Msame sector · same stage
Healthy America, LLCHealthtechSeries B$31.0M$435.9Msame sector · same stage
Charta Health, Inc.HealthtechSeries B$30.1M$148.8Msame sector · same stage
BrightSpring Health Services, Inc.HealthtechSeries B$30.0M$192.8Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Health Precision Inc.HealthtechSeries B$98.9M87%
Robin Health IncHealthtechPre-Seed$1.3M86%
Thrive Health Tech, Inc.HealthtechSeries A$16.5M85%
Health at Scale CorpHealthtechSeries A$316.0M85%
Limber Health, Inc.HealthtechSeries B$225.4M85%
Healthe, Inc.HealthtechSeries B$465.2M85%
Precision Health Reports, Inc.HealthtechPre-Seed$6.3M85%
Annie Health, Inc.HealthtechPre-Seed$1.9M85%
Frequently asked
How much funding has Diameter Health, Inc. raised?
Diameter Health, Inc. has raised approximately $30.7M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Diameter Health, Inc.'s estimated valuation?
Provath's modeled valuation for Diameter Health, Inc. is approximately $418.7M (modeled range $42.3M–$1.6B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Diameter Health, Inc. at?
Diameter Health, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Fri Sep 11.
What does Diameter Health, Inc. do and where is it based?
Diameter Health, Inc. operates in the Healthtech sector, based in Farmington.
Explore related

See where Diameter Health, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Diameter Health, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.